TVT

Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology | March 22, 2017

March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...

RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis

A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.

Feature | Heart Valve Technology | March 21, 2017

March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood...

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

Boston Scientific Lotus TAVR valve, Lotus transcatheter aortic valve
News | Heart Valve Technology | March 09, 2017

March 9, 2017 — Boston Scientific announced the German District Court of Düsseldorf has determined that Edwards...

Lotus Edge Valve, boston scientific, TAVR, TAVI, patent, patent lawsuit

The Boston Scientific Lotus TAVR valve.

News | Heart Valve Technology | March 03, 2017

March 3, 2017 — In a United Kingdom patent case involving a Edwards Lifesciences lawsuit against Boston Scientific ...

Claret Medical Sentinel Cerebral Protection System (CPS), FDA, TAVR embolic protection, transcatheter aortic valve replacement (TAVR).
News | Heart Valve Technology | February 28, 2017

February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...

Tendyne Mitral valve

The Tendyne mitral valve being implanted. 

News | Heart Valve Technology | January 16, 2017

January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the...

Videos | Heart Valve Technology | January 03, 2017

This video, provided by Valtech, demonstrates the Cardioband transcatheter mitral annuloplasty system. It allows...

NaviGate, GATE tricuspid Atrioventricular Valved Stent AVS, transcatheter tricuspid valve replacement
News | Heart Valve Technology | December 31, 2016

December 31, 2016 — NaviGate Cardiac Structures Inc. (NCSI) announced that a novel valved stent that can capture the...

valtech cardioband transcatheter annuloplasty repair for FMR, functional mitral regurgitation

The Cardioband system is among several new transcatheter mitral repair systems entering clinical trials. In many cases, repair of the native valve is preferred over replacing the valve in open-chest surgical cases. This technology will allow a less invasive alternative. 

Feature | Heart Valve Technology | December 29, 2016 | Azeem Latib, M.D.

The Cardioband System (Valtech) has recently been introduced as a potential option for transcatheter repair of the...

Cardioband, valtech, Edwards Lifesciences, transcatheter mitral repair, transcatheter tricuspid valve repair, transcatheter annuloplasty

An illustration of how the transcatheter Cardioband System can used as a non-surgical form on annuloplasty repair. 

News | Heart Valve Technology | December 02, 2016

December 2, 2016 — Edwards Lifesciences Corp. announced this week it has agreed to acquire Valtech Cardio Ltd., a...

Videos | Heart Valve Technology | November 09, 2016

A discussion with Michael Reardon, M.D. about the state of transcatheter aortic valve replacement (TAVR) as of late...

Sentinel, TAVR, TAVI, embloic protection
News | Heart Valve Technology | November 07, 2016

November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel...

Overlay Init